AXLICAB
Live / Applied — Fourth extension granted (statement of use) (as of 16 Dec 2025)
What this means for you
Not registered yet, but its 13 Dec 2022 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97715601
- Mark type
- Stylized text
- Filed
- 13 Dec 2022
- Published for opposition
- 31 Oct 2023
- Attorney of record
- Paul C. Llewellyn
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals in the nature of immuno-oncology preparations; Pharmaceutical products for the treatment of cancer; Biological preparations for the treatment of cancer; Anti-cancer preparations
Owner
- BioAtla, Inc., San Diego, CA, US
- BioAtla, Inc., San Diego, CA, US
Prosecution history
- 16 Dec 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Dec 2025 — SOU EXTENSION 4 GRANTED
- 15 Dec 2025 — SOU EXTENSION 4 FILED
- 15 Dec 2025 — SOU TEAS EXTENSION RECEIVED
- 08 Oct 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 08 Oct 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 08 Oct 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 25 Jun 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 24 Jun 2025 — SOU EXTENSION 3 GRANTED
- 24 Jun 2025 — SOU EXTENSION 3 FILED
- 24 Jun 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 19 Dec 2024 — SOU EXTENSION 2 GRANTED
- 18 Dec 2024 — SOU EXTENSION 2 FILED
- 18 Dec 2024 — SOU TEAS EXTENSION RECEIVED